SYRINGALDOXIME

Suppliers

Names

[ CAS No. ]:
5032-13-3

[ Name ]:
SYRINGALDOXIME

[Synonym ]:
3,5-Dimethoxy-4-hydroxybenzaldehyde oxime
3,5-Dimethoxy-4-hydroxy-benzaldoxim
Syringaldehyde oxime
4-Hydroxy-3,5-dimethoxybenzaldehyde oxime
3,5-dimethoxy-4-hydroxybenzaldoxime
Syringaldehyd-oxim
Syringaldoxime
BENZALDEHYDE,3,5-DIMETHOXY-4-HYDROXY-,OXIME
4-hydroxy-3,5-dimethxoybenzaldehyde oxime

Chemical & Physical Properties

[ Density]:
1.28g/cm3

[ Boiling Point ]:
405.2ºC at 760mmHg

[ Molecular Formula ]:
C9H11NO4

[ Molecular Weight ]:
197.18800

[ Flash Point ]:
198.8ºC

[ Exact Mass ]:
197.06900

[ PSA ]:
71.28000

[ LogP ]:
1.21750

[ Index of Refraction ]:
1.558

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CU5770000
CHEMICAL NAME :
Benzaldehyde, 3,5-dimethoxy-4-hydroxy-, oxime
CAS REGISTRY NUMBER :
5032-13-3
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C9-H11-N-O4
MOLECULAR WEIGHT :
197.21
WISWESSER LINE NOTATION :
QNU1R DQ CO1 EO1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 7,178,1964

Safety Information

[ HS Code ]:
2928000090

Precursor & DownStream

Precursor

DownStream

  • 4-hydroxy-3,5-dimethoxybenzonitrile
  • 4-(aminomethyl)-2,6-dimethoxyphenol

Customs

[ HS Code ]: 2928000090

[ Summary ]:
2928000090 other organic derivatives of hydrazine or of hydroxylamine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%


Related Compounds

  • Syringaldoxime
  • 6-cyclopropyl-5-fluoro-2-[4-(5-oxo-1-phenylpyrrolidine-3-carbonyl)piperazin-1-yl]-5H-pyrimidin-4-one
  • 3-butyl-1-methyl-4aH-thieno[3,2-d]pyrimidin-1-ium-2,4-dione
  • rac-(3R,4S)-4-[2-(oxolan-2-yl)ethyl]pyrrolidin-3-ol
  • 5,6-Dimethyl-3-[2-oxo-2-[4-(6-oxo-3-phenyldiazinan-4-yl)piperazin-1-yl]ethyl]pyrimidin-4-one
  • [4-(3,5-Dimethylpyrazolidin-4-yl)sulfonyl-1,4-diazepan-1-yl]-(4-phenyloxan-4-yl)methanone
  • 1-Cyclohexyl-4-[[3-(2-ethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazine-2,3-dione
  • 3-[3-[4-(5-Fluoro-4-methyl-6-oxo-1,3-diazinan-2-yl)piperazin-1-yl]-3-oxopropyl]quinazolin-4-one
  • N-[1-(5-fluoro-6-phenylpyrimidin-4-yl)azetidin-3-yl]-N,1-dimethyl-2,6-dioxo-1,3-diazinane-5-carboxamide
  • 6-Cyclopropyl-5-fluoro-2-[4-(9-methylpurin-6-yl)piperazin-1-yl]-1,3-diazinan-4-one
  • 2-oxo-N-[2-(4-oxothieno[2,3-d]pyrimidin-3-yl)ethyl]piperidine-4-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.